Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Common Stock, par value $0.001 per share · CUSIP: 00166B105

Event date: 2026-02-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 13,117,106.00 · Class: 9.9%

  • Peter Kolchinsky

    Shares: 13,117,106.00 · Class: 9.9%

  • Rajeev Shah

    Shares: 13,117,106.00 · Class: 9.9%

  • RA Capital Healthcare Fund, L.P.

    Shares: 13,117,106.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-26-000010
Form type
SCHEDULE 13G
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Feb 09, 2026
Reporting period
Feb 02, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub